glp-1 companies Big Food Is Learning to Love Weight-Loss Drugs The New York Times spotlighted

SmartPill, a novel ambulatory diagnostic test for measuring gastric emptying in health and disease

Inside youll get: Plateau basics so you can tell the difference between a real stall and normal weight-loss noise

However, a July 2025 study published in eClinicalMedicine notes that people who stop taking Ozempic and other GLP-1s tend to regain the weight they had lost

Some research links it to reductions in visceral fat

Its only cost him a $25 monthly co-pay under his Blue Cross plan provided by the town of Sharon

There is limited evidence supporting this approach, and it should be reserved for severe, refractory cases under gastroenterology specialist guidance